Guardian Pharmacy Services (GRDN) Liabilities and Shareholders Equity (2023 - 2026)

Guardian Pharmacy Services' Liabilities and Shareholders Equity history runs 4 years deep, the most recent figure standing at $426.9 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 27.83% year-over-year to $426.9 million; the TTM figure through Mar 2026 stood at $1.6 billion (up 58.15% YoY), while the FY2025 annual figure was $412.7 million, up 28.63% from the prior year.
• Liabilities and Shareholders Equity came in at $426.9 million for Q1 2026 at Guardian Pharmacy Services, up from $412.7 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $426.9 million in Q1 2026 to a low of $271.2 million in Q4 2023.
• A 4-year average of $357.5 million and a median of $352.2 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• On a YoY basis, Liabilities and Shareholders Equity climbed as much as 28.63% in 2025 and fell as far as 12.07% in 2025.
• Guardian Pharmacy Services' Liabilities and Shareholders Equity stood at $271.2 million in 2023, then increased by 18.31% to $320.8 million in 2024, then advanced by 28.63% to $412.7 million in 2025, then increased by 3.46% to $426.9 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $426.9 million, $412.7 million, and $390.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison